Rabkozol-DSR is a combination of Rabeprazole 20 mg and Domperidone 30 mg, formulated for the management of acid-related gastrointestinal symptoms. Rabeprazole is a proton pump inhibitor (PPI) that reduces the production of excess stomach acid, while Domperidone is a prokinetic agent that helps improve gastrointestinal motility.
This combination may be prescribed for acidity, heartburn, acid reflux, indigestion, and associated symptoms such as nausea or vomiting, particularly when gastrointestinal motility contributes to the patient's symptoms.
Each sustained-release capsule contains Rabeprazole 20 mg + Domperidone 30 mg and is manufactured under quality-controlled conditions under the KureKraft brand.